Clinical Trial Update: Use of Tranexamic Acid in Reduction Mammoplasty [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating tranexamic acid to reduce postoperative hematoma and venous thromboembolism after reduction mammoplasty has been completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematoma Post-surgery
• Reduction Mammoplasty Complications
• Venous Thromboembolism

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Hematoma Postoperative, Venous Thromboembolism | Phase 4 | Status: COMPLETED | Results posted: 2023-04-10